Greg Baldwin

Mr. Baldwin was most recently Chairman and CEO of Baxa Corporation, a leader in devices, systems, and software for the handling, packaging, and tracking of fluid medications in a critical care setting. Under his leadership from 1997 until its sale to Baxter Corporation in 2011, the company sales grew from $25 million to over $170 million. As CEO, he led the eight-member board of directors and led a minority recap resulting in Goldman Sach’s private equity group owning 27% of the company. He was also an early investor and lead director in Pharmacy OneSource, an innovative software-as-a-service business that had a successful exit in 2010.

Prior to being CEO of Baxa, Mr. Baldwin spent fourteen years in Sales and Marketing roles for Baxa, Sprint, and PictureTel. He has an MBA from Boston University.